BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 26530266)

  • 21. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An extent of resection threshold for seizure freedom in patients with low-grade gliomas.
    Xu DS; Awad AW; Mehalechko C; Wilson JR; Ashby LS; Coons SW; Sanai N
    J Neurosurg; 2018 Apr; 128(4):1084-1090. PubMed ID: 28548599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
    Dahlrot RH
    Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcome of postoperative irradiation in patients with newly diagnosed WHO grade III anaplastic gliomas.
    Nagy M; Schulz-Ertner D; Bischof M; Welzel T; Hof H; Debus J; Combs SE
    Tumori; 2009; 95(3):317-24. PubMed ID: 19688970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
    Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51.
    Daniels TB; Brown PD; Felten SJ; Wu W; Buckner JC; Arusell RM; Curran WJ; Abrams RA; Schiff D; Shaw EG
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):218-24. PubMed ID: 21549518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereotactic iodine-125 brachytherapy for the treatment of WHO grades II and III gliomas located in the central sulcus region.
    Ruge MI; Kickingereder P; Grau S; Dorn F; Galldiks N; Treuer H; Sturm V
    Neuro Oncol; 2013 Dec; 15(12):1721-31. PubMed ID: 24046261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part I: Treatment modalities of radiation therapy.
    Kortmann RD; Timmermann B; Taylor RE; Scarzello G; Plasswilm L; Paulsen F; Jeremic B; Gnekow AK; Dieckmann K; Kay S; Bamberg M
    Strahlenther Onkol; 2003 Aug; 179(8):509-20. PubMed ID: 14509949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome.
    Devaux BC; O'Fallon JR; Kelly PJ
    J Neurosurg; 1993 May; 78(5):767-75. PubMed ID: 8468607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of biopsy in the management of patients with presumed diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.
    Ragel BT; Ryken TC; Kalkanis SN; Ziu M; Cahill D; Olson JJ
    J Neurooncol; 2015 Dec; 125(3):481-501. PubMed ID: 26530259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
    Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
    Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of gamma knife radiosurgery in the management of intracranial gliomas.
    Deora H; Tripathi M; Tewari MK; Ahuja CK; Kumar N; Kaur A; Kamboj P
    Neurol India; 2020; 68(2):290-298. PubMed ID: 32415008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.
    Farrell C; Shi W; Bodman A; Olson JJ
    J Neurooncol; 2020 Nov; 150(2):269-359. PubMed ID: 33215345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study.
    Shaw E; Arusell R; Scheithauer B; O'Fallon J; O'Neill B; Dinapoli R; Nelson D; Earle J; Jones C; Cascino T; Nichols D; Ivnik R; Hellman R; Curran W; Abrams R
    J Clin Oncol; 2002 May; 20(9):2267-76. PubMed ID: 11980997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biopsy versus resection for the management of low-grade gliomas.
    Jiang B; Chaichana K; Veeravagu A; Chang SD; Black KL; Patil CG
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD009319. PubMed ID: 28447767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective clinical trials of intracranial low-grade glioma in adults and children.
    Shaw EG; Wisoff JH
    Neuro Oncol; 2003 Jul; 5(3):153-60. PubMed ID: 12816721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiation necrosis or glioma recurrence: is computer-assisted stereotactic biopsy useful?
    Forsyth PA; Kelly PJ; Cascino TL; Scheithauer BW; Shaw EG; Dinapoli RP; Atkinson EJ
    J Neurosurg; 1995 Mar; 82(3):436-44. PubMed ID: 7861222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcomes after supratotal resection of diffuse low-grade gliomas: a consecutive series with 11-year follow-up.
    Duffau H
    Acta Neurochir (Wien); 2016 Jan; 158(1):51-8. PubMed ID: 26530708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-Aminolevulinic Acid Hydrochloride (5-ALA)-Guided Surgical Resection of High-Grade Gliomas: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(9):1-92. PubMed ID: 32194883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.